Approval · Notice of Compliance 24929 · 2020
OMVYENCE: Notice of Compliance 24929
Issued December 29, 2020
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 24929
- Date
- December 29, 2020
- Company
- Janssen Inc.Toronto, Ontario, Canada
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- Labelling Only
- Reason
- Additional product name
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| OMVYENCE | 02510308 | Approved |
Medicinal ingredients
- INFLIXIMAB 100 MG per VIAL